Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first...
Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta, ...
CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first-line treatment for advanced NSCLC ( Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta, USA )
2 Jun 2020
ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer
Prof Benjamin Besse and Dr Alex Spira
ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer ( Prof Benjamin Besse and Dr Alex Spira )
2 Jun 2020
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy f...
Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA )
31 May 2020
Brigatinib for NSCLC, latest research and overcoming complications
Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Brigatinib for NSCLC, latest research and overcoming complications ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020
Sym015 shows superior specificity compared to TKIs for NSCLC
Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Sym015 shows superior specificity compared to TKIs for NSCLC ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020
ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer
Prof Roy Herbst - Yale Cancer Center, New Haven, USA
ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )
29 May 2020
Do immune checkpoint inhibitors work in EGFR mutant lung cancer?
Dr Edward Garon - UCLA Medical Center, Santa Monica, USA
Do immune checkpoint inhibitors work in EGFR mutant lung cancer? ( Dr Edward Garon - UCLA Medical Center, Santa Monica, USA )
22 May 2020
COVID-19: Risk of millions relapsing back to smoking
Dr Sudhanshu Patwardhan - Centre for Health Research and Education, Southampton,...
COVID-19: Risk of millions relapsing back to smoking ( Dr Sudhanshu Patwardhan - Centre for Health Research and Education, Southampton, UK )
22 May 2020
TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patie...
Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA
TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19 ( Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA )
21 May 2020
COVID-19: Management of non-small cell lung cancer patients during the coronavir...
Dr Heather Wakelee - Stanford University, Stanford, USA
COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic ( Dr Heather Wakelee - Stanford University, Stanford, USA )
12 May 2020
Prostate cancer patients receiving androgen-deprivation therapies shown to be at...
Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerla...
Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19 ( Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland )
7 May 2020
COVID-19: The situation in Florida and managing lung cancer patients
Dr. Luis Raez - Memorial Healthcare System, Florida, Miami
COVID-19: The situation in Florida and managing lung cancer patients ( Dr. Luis Raez - Memorial Healthcare System, Florida, Miami )
27 Apr 2020